Page 152 - Read Online
P. 152
51. Ackerman Z, Cominelli F, Reynolds TB. Effect of misoprostol on microglia and facilitates neurogenesis in oxygen‑glucose‑deprived
ibuprofen‑induced renal dysfunction in patients with decompensated hippocampal slice cultures. Eur J Pharmacol 2008;592:55‑61.
cirrhosis: results of a double‑blind placebo‑controlled parallel group 55. Schindler JF, Monahan JB, Smith WG. p38 pathway kinases as
study. Am J Gastroenterol 2002;97:2033‑9. anti‑inflammatory drug targets. J Dent Res 2007;86:800‑11.
52. Hawkey CJ. Non‑steroidal anti‑inflammatory drug
gastropathy: causes and treatment. Scand J Gastroenterol
Suppl 1996;220:124‑7. Cite this article as: Montoliu C, Llansola M, Felipo V. Neuroinflammation
53. Agusti A, Cauli O, Rodrigo R, Llansola M, Hernandez‑Rabaza V, and neurological alterations in chronic liver diseases. Neuroimmunol
Neuroinflammation 2015;2(3):138-44.
Felipo V. p38 MAP kinase is a therapeutic target for
hepatic encephalopathy in rats with portacaval shunts. Gut Source of Support: Supported by grants from Ministerio de Ciencia e
Innovación (SAF2011-23051, CSD2008-00005), Consellería Educación
2011;60:1572‑9. Generalitat Valenciana (PROMETEO-2009-027, PROMETEOII/2014/033,
54. Strassburger M, Braun H, Reymann KG. Anti‑inflammatory ACOMP/2012/066, and ACOMP/2013/101). Conflict of Interest: No.
treatment with the p38 mitogen‑activated protein kinase inhibitor
SB239063 is neuroprotective, decreases the number of activated Received: 02-01-2015; Accepted: 19-05-2015
144 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 PB